2018
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis
Hendricks W, Zismann V, Sivaprakasam K, Legendre C, Poorman K, Tembe W, Perdigones N, Kiefer J, Liang W, DeLuca V, Stark M, Ruhe A, Froman R, Duesbery N, Washington M, Aldrich J, Neff M, Huentelman M, Hayward N, Brown K, Thamm D, Post G, Khanna C, Davis B, Breen M, Sekulic A, Trent J. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis. PLOS Genetics 2018, 14: e1007589. PMID: 30188888, PMCID: PMC6126841, DOI: 10.1371/journal.pgen.1007589.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCell CycleCell ProliferationComparative Genomic HybridizationDNA Mutational AnalysisDog DiseasesDogsFemaleMaleMelanomaMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Receptor-Like Protein Tyrosine Phosphatases, Class 3Signal TransductionSkin NeoplasmsTissue Array AnalysisConceptsLow point mutation ratePowerful comparative modelComparative genomic analysisCell cycle controlPoint mutation rateSingle nucleotide polymorphism arrayNucleotide polymorphism arrayWhole-genome sequencingArray comparative genomic hybridizationHuman melanomaComparative genomic hybridizationGenomic analysisRNA sequencingCycle controlGenome sequencingMutation rateGenomic landscapePolymorphism arrayCopy numberMutational landscapeMutational signaturesGenomic hybridizationRecurrent alterationsMulti-platform analysisMutations
2012
Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision
Dank G, Rassnick K, Sokolovsky Y, Garrett L, Post G, Kitchell B, Sellon R, Kleiter M, Northrup N, Segev G. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Veterinary And Comparative Oncology 2012, 12: 78-84. PMID: 22737988, DOI: 10.1111/j.1476-5829.2012.00338.x.Peer-Reviewed Original ResearchConceptsMalignant melanomaOverall median progression-free survivalMedian progression-free survivalProgression-free survival eventsAdjuvant carboplatin chemotherapyCommon oral malignancyMalignant oral melanomasMedian overall survivalProgression-free survivalOral malignant melanomaTreatment of dogsNumber of dosesCanine malignant melanomaCause of deathAdjuvant carboplatinCarboplatin chemotherapyMedian dosageOverall survivalSurgical resectionSystemic therapyLocal recurrenceOral malignanciesSurgical excisionRetrospective studyOral melanoma